Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 437

1.

Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.

Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ.

Am J Clin Pathol. 2001 Jan;115(1):85-98.

PMID:
11190811
[PubMed - indexed for MEDLINE]
Free Article
2.

E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.

Wahed A, Connelly J, Reese T.

Ann Diagn Pathol. 2002 Dec;6(6):349-51.

PMID:
12478484
[PubMed - indexed for MEDLINE]
3.

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.

De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM.

J Pathol. 1997 Dec;183(4):404-11.

PMID:
9496256
[PubMed - indexed for MEDLINE]
4.

Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma.

Choi YJ, Pinto MM, Hao L, Riba AK.

Mod Pathol. 2008 Oct;21(10):1224-37. doi: 10.1038/modpathol.2008.106. Epub 2008 Jun 27.

PMID:
18587329
[PubMed - indexed for MEDLINE]
Free Article
5.

Aberrant expression of E-cadherin in lobular carcinomas of the breast.

Da Silva L, Parry S, Reid L, Keith P, Waddell N, Kossai M, Clarke C, Lakhani SR, Simpson PT.

Am J Surg Pathol. 2008 May;32(5):773-83. doi: 10.1097/PAS.0b013e318158d6c5.

PMID:
18379416
[PubMed - indexed for MEDLINE]
6.

Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.

Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ.

Mod Pathol. 2003 Jul;16(7):674-8.

PMID:
12861063
[PubMed - indexed for MEDLINE]
Free Article
7.

Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization.

Jacobs TW, Pliss N, Kouria G, Schnitt SJ.

Am J Surg Pathol. 2001 Feb;25(2):229-36.

PMID:
11176072
[PubMed - indexed for MEDLINE]
8.

Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.

Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.

Anticancer Res. 2005 May-Jun;25(3A):1615-22.

PMID:
16033070
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

[Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].

Chipysheva TA, Ermilova VD, Vishnevskaia IaV, Vasil'ev IuM.

Arkh Patol. 2005 Nov-Dec;67(6):24-7. Russian.

PMID:
16405017
[PubMed - indexed for MEDLINE]
11.

The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.

Esposito NN, Chivukula M, Dabbs DJ.

Mod Pathol. 2007 Jan;20(1):130-8. Epub 2006 Nov 24.

PMID:
17143261
[PubMed - indexed for MEDLINE]
Free Article
12.

Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.

Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR.

J Pathol. 1993 Feb;169(2):245-50.

PMID:
8383197
[PubMed - indexed for MEDLINE]
13.

Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis.

Maluf HM, Swanson PE, Koerner FC.

Am J Surg Pathol. 2001 Feb;25(2):237-44.

PMID:
11176073
[PubMed - indexed for MEDLINE]
14.

Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

Moll R, Mitze M, Frixen UH, Birchmeier W.

Am J Pathol. 1993 Dec;143(6):1731-42.

PMID:
8256859
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.

Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ.

Am J Clin Pathol. 1996 Apr;105(4):394-402.

PMID:
8604681
[PubMed - indexed for MEDLINE]
16.

E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer.

Nurismah MI, Noriah O, Suryati MY, Sharifah NA.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):699-702.

PMID:
19256762
[PubMed - indexed for MEDLINE]
Free Article
17.

[E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast].

Han A, Xiong M, Li Z, Liang Y.

Zhonghua Bing Li Xue Za Zhi. 2001 Feb;30(1):27-30. Chinese.

PMID:
11866953
[PubMed - indexed for MEDLINE]
18.

High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.

Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO.

Am J Surg Pathol. 2007 Mar;31(3):417-26.

PMID:
17325484
[PubMed - indexed for MEDLINE]
19.

Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.

Lehr HA, Folpe A, Yaziji H, Kommoss F, Gown AM.

Am J Clin Pathol. 2000 Aug;114(2):190-6.

PMID:
10941333
[PubMed - indexed for MEDLINE]
Free Article
20.

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.

Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Valgeirsson H, Lambros M, Ashworth A, Palacios J, Schmitt F, Lakhani SR.

J Pathol. 2005 Sep;207(1):1-13.

PMID:
15957152
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk